Dyne Therapeutics DYN
NASDAQ DYN
$16.40 +0.13 (+0.80%)
As of: Oct 21, 2026 · 11:41 AM EDT

Dyne Therapeutics (DYN) Debt Ratio (2020 - 2026)

Updated

Dyne Therapeutics' (DYN) Debt Ratio came in at 0.03 for Q3 2020.

Analysis

Dyne Therapeutics (DYN) Debt Ratio (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 0.24
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 0.52
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 0.42
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 0.08
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 0.28
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 0.53
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 0.31
10 Dyne Therapeutics 2.72 Bn -1.06 Bn - 0.20
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.20
Mar 31, 2026 0.14
Dec 31, 2025 0.13
Sep 30, 2025 0.11
Jun 30, 2025 0.14
Sep 30, 2020 0.03
API Access

Dyne Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=DYN&period=max&api_key=YOUR_API_KEY